TheFly.com
Start Free Trial
Open Search
keyboard_arrow_down
Type symbol to search
This symbol is non-existent:
List is empty.
Search
GTHX
G1 Therapeutics
$
()
GTHX
G1 Therapeutics sees FY24 COSELA revenue $60M-$70M
GTHX
2/28/2024 - 06:37am
G1 Therapeutics reports Q4 EPS (21c), consensus (27c)
GTHX
2/28/2024 - 06:36am
Biotech Alert: Searches spiking for these stocks today
ADIL
,
STOK
,
BCYC
…
2/16/2024 - 11:22am
Biotech Alert: Searches spiking for these stocks today
CBAY
,
BCYC
,
MACK
…
2/15/2024 - 11:05am
G1 Therapeutics price target lowered by $2 at Needham, here's why
GTHX
2/13/2024 - 07:48am
G1 Therapeutics tumbles after DMC recommends Phase 3 trial continues
GTHX
2/13/2024 - 07:33am
G1 Therapeutics presents post hoc analyses on trilaciclib with chemotherapy
GTHX
12/5/2023 - 09:31am
G1 Therapeutics price target lowered to $9 from $11 at H.C. Wainwright
GTHX
11/2/2023 - 06:05am
G1 Therapeutics sees FY23 COSELA net revenue $44M-$47M
GTHX
11/1/2023 - 06:36am
G1 Therapeutics reports Q3 EPS (35c), consensus (33c)
GTHX
11/1/2023 - 06:34am
G1 Therapeutics announces four posers on real-world evidence on trilaciclib
GTHX
10/27/2023 - 07:12am
G1 Therapeutics' COSELA recommended in updated SCLC guidelines
GTHX
10/18/2023 - 08:03am
G1 Therapeutics downgraded to Underweight from Neutral at JPMorgan
GTHX
10/6/2023 - 05:20am
Biotech Alert: Searches spiking for these stocks today
GTHX
,
APVO
,
TCON
…
8/4/2023 - 11:10am
G1 Therapeutics reaffirms FY23 COSELA net revenue view $50M-$60M
GTHX
8/2/2023 - 06:46am
dynamic_feed
Breaking News
search
Search
menu
Menu